Direxion Daily S&P Biotech Bear 3X Shares (LABD)

23.77
Delayed Data
As of 4:00pm ET
 -0.53 / -2.18%
Today’s Change
12.30
Today|||52-Week Range
84.87
-5.94%
Year-to-Date

Investment Objective

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

5 Top-Performing Leveraged/Inverse ETFs of July
Aug 02 / Zacks.com - Paid Partner Content
 

Performance

1 month+28.74% 3 years-63.18%
3 months+19.32% 5 years-64.53%
1 year-66.18% Since inception-60.74%
Data through 08/03/2021

Quote Details

Previous close$24.30
Open day’s range23.76 – 25.14
Net asset value (NAV)24.25 (08/02/2021)
Daily volume1,242,890
Average volume (3 months)2,969,010
Data as of 4:00pm ET, 08/03/2021

Peer Comparisonvs. Trading--inverse equity ETFs

 LABDCategory
Performance 5-yr return-64.53%-29.79%
Expense Gross exp ratio1.11%--
Risk 5 year sharpe ratio-1.07--
Net assets$56.3M--
Average market cap--$247.5B
Average P/E--23.9
Dividend / Share--9.54%

Competitors

SPDN Direxion Daily S&P 500® Bear 1X Shares
TAIL Cambria Tail Risk ETF
SH ProShares Short S&P500

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
FTIXX Goldman Sachs Financial Square Treasury Instruments Fund Institutional Shares60.44%
DAPXX Dreyfus Government Securities Cash Management Administrative Shares6.25%
-- 2.20%